The experimental data in our study revealed that the ISL1/KDM6B/SNAI1 axis restrict progression of NAFLD, providing theoretical basis on the pathogenesis of NAFLD and it being a potential target for treating NAFLD. The gene discussed is SNAI1; the disease is metabolic dysfunction-associated steatotic liver disease.